Please login to the form below
UK Biobank
This page shows the latest UK Biobank news and features for those working in and with pharma, biotech and healthcare.
AbbVie, Biogen and Pfizer collaboration creates new resource for genetic exome sequence analysis
Working with the Broad Institute, the three companies completed data processing and conducted single variant and gene-based association testing with nearly 4, 000 UK Biobank phenotypes. ... The health resource’s whole exome sequencing data was
Latest news
-
Novartis plans inclisiran trial in the UK
The Swiss pharma is currently planning a primary prevention study with cholesterol-lowering drug inclisiran in the UK, building on the methods used to recruit patients into the UK Biobank. ... The UK Biobank is a national and international health
-
Evotec and Vifor announce joint venture for kidney disease treatments
The discovery of novel nephrology therapeutics will be aided by analysis of clinical data provided by Evotec from the UK kidney biobank NURTuRE.
-
Mistrust of pharma still blocking NHS collaborations
Greater Manchester is leader in breaking down barriers. What’s stopping pharma and the NHS working together more often, and in more parts of the UK? ... The 100, 000 Genomes Project, and the UK Biobank are two leading examples of this, which both sides
-
EMD Serono allies with ‘free sequencing’ firm Nebula
This approach is already being used in the UK Biobank project – backed by a consortium of pharma and biotech companies including Regeneron, AbbVie, Alnylam, AstraZeneca, Biogen, and Pfizer – with data now ... Along with UK Biobank other initiatives
-
UK heart deaths rise for first time in 50 years
But we’re seeing more people die each year from heart and circulatory diseases in the UK before they reach their 75th, or even 65th, birthday. ... genetic data form the UK Biobank to better understand heart disease.
More from news
Approximately 2 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
AI and genomics: a revolution in drug discovery and development
in the UK Biobank as an example.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
How whole genome sequencing is revolutionising the rare disease patient experience
UK Biobank is the most detailed, long-term prospective health research study in the world. ... So far, over 20, 000 researchers have used data from the UK Biobank in their studies.
-
#DemandDiversity: The science behind diversity
1) It’s been found that Black, Indian, Pakistani and Chinese participants are all underrepresented in the UK Biobank, a huge genetic database, by at least one third. ... And when this is converted to the number of times the data from an individual were
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
